First‐line R‐CVP
versus
R‐CHOP induction immunochemotherapy for indolent lymphoma with rituximab maintenance. A multicentre, phase III randomized study by the Polish Lymphoma Research Group PLRG4
Keyword(s):
2013 ◽
Vol 31
(27)
◽
pp. 3351-3359
◽
Keyword(s):
Keyword(s):
2015 ◽
Vol 33
(30)
◽
pp. 3467-3474
◽
2007 ◽
Vol 2
(8)
◽
pp. S632
◽
Keyword(s):
2020 ◽
Keyword(s):
Keyword(s):
Keyword(s):
2015 ◽
Vol 33
(15_suppl)
◽
pp. 507-507
◽
Keyword(s):
2020 ◽
Vol 38
(15_suppl)
◽
pp. 9518-9518
◽
Keyword(s):